Accenture’s Buyback Is a Confidence Signal, Not a Clean Rerating

Written by Cassian Vance

Accenture’s fresh buyback decision is the kind of announcement that deserves more than the usual capital-allocation applause. On June 23, the company added $2 billion to its fiscal 2026 repurchase plan, taking expected annual buybacks to $7.5 billion and total expected shareholder returns to $11.5 billion. That is not a symbolic gesture. It is management saying, quite directly, that the stock does not reflect Accenture’s role in AI-driven reinvention or the strength of its operating model.

The market should take that signal seriously, but not uncritically. Accenture is making a credible case that it remains one of the safest scale platforms for enterprise AI services. At the same time, a bigger buyback does not automatically erase the execution questions attached to consulting demand, federal exposure, and the difficulty of converting AI enthusiasm into sustained revenue acceleration. The right read is constructive, not euphoric.

The operating backdrop matters. In its June 18 results, Accenture said fiscal third-quarter performance delivered solid revenue, strong profitability, EPS growth, and robust free cash flow, while guiding to full-year local-currency revenue growth of 3% to 4%, or 4% to 5% excluding an estimated one-point drag from U.S. federal business. That is not hypergrowth. But it is exactly the sort of stable, cash-generative profile that gives management room to be aggressive with repurchases without looking defensive.

What the buyback really does is sharpen the valuation debate. Based on the latest Nasdaq summary snapshot, Accenture was trading around a $127 reference price with an $84.8 billion market cap. The peer set is revealing. Finviz shows Accenture at roughly 10.1x trailing earnings, a 1.29 PEG, and about 5.9x EV/EBITDA. That is not expensive in absolute terms, especially for a company with Accenture’s scale, customer density, and cash conversion. But it is also not so cheap that investors can ignore the risk that AI consulting demand proves more incremental than transformational over the next several quarters.

This is where the comparison with IBM, Cognizant, and EPAM becomes useful. IBM trades at materially richer multiples, with Finviz putting it at roughly 23.4x earnings and 15.6x EV/EBITDA. Investors are paying for a different mix there: more infrastructure, more software leverage, and a more visible platform element within the AI narrative. Cognizant screens much cheaper, at about 8.9x earnings and 4.8x EV/EBITDA, but that discount also reflects a less differentiated growth identity. EPAM, meanwhile, sits near 11.0x earnings and 4.8x EV/EBITDA, with a lower PEG than Accenture and a more engineering-centric AI transformation story, but it brings higher volatility and less balance-sheet comfort.

Accenture’s advantage is that it sits in a sweet spot between these models. It is not as infrastructure-heavy as IBM, which limits the premium investors will pay. But it is more globally scaled and strategically central than Cognizant, and less niche and more balance-sheet-secure than EPAM. In practical terms, Accenture is still one of the few firms large enterprises trust to connect boardroom AI ambition with the tedious reality of implementation across data, workflows, cybersecurity, supply chains, and operating models.

That is why management’s language around the share price matters. Companies do not usually lean this hard into undervaluation rhetoric unless they believe the market is missing something durable. The bullish case is that Accenture is using temporary skepticism around services demand to retire stock at an attractive valuation just as enterprise AI budgets become more real, less experimental, and more embedded in large-account spending plans. If that is correct, the buyback could look less like financial engineering and more like opportunistic capital deployment.

The bear case is simpler. Consulting has always been vulnerable to elongated client decision cycles, discretionary-spend caution, and the tendency of new technology narratives to monetize more slowly than expected. Accenture’s own guidance still reads like disciplined progress, not a breakout. If AI projects continue to produce a lot of pilot activity but only modest near-term revenue acceleration, the stock may deserve to remain in the market’s middle ground: respected, cash-rich, but not fully rerated.

My price target of $170 for Accenture reflects that balance. It sits below the more optimistic external targets but still assumes investors will reward the combination of repurchase intensity, resilient execution, and a still-underappreciated role in enterprise AI deployment. I view the name as a BUY because the valuation is reasonable relative to quality, and because management’s willingness to step up buybacks adds downside support.

IBM remains a HOLD at $285. The company has built a credible hybrid cloud and AI position, but much of that strategic improvement is already capitalized in the multiple. Cognizant is a HOLD at $48: statistically inexpensive, but still missing the sharper strategic identity required for a durable rerating. EPAM is the more speculative BUY at $96, because the engineering-first AI transformation angle could produce a stronger percentage recovery if execution continues to firm.

The most important conclusion is that Accenture’s announcement should not be read as a climax. It should be read as a signal. Management is telling the market that AI services, at scale, are worth more than today’s multiple implies. I agree with that judgment. I just do not think the rerating will be clean enough to justify treating Accenture like a pure AI winner overnight. The stock is attractive here, but it still needs to earn part of its next leg higher.